🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/09/2025 | 81,76 | 81,94 | 80,26 | 80,40 | -1,36% | 2,05% | 11.986.400 |
| 19/09/2025 | 81,81 | 82,40 | 81,00 | 81,51 | -0,02% | 1,71% | 25.627.800 |
| 18/09/2025 | 81,22 | 81,69 | 80,82 | 81,53 | +0,48% | 1,07% | 10.458.900 |
| 17/09/2025 | 80,98 | 82,25 | 80,80 | 81,14 | +0,06% | 1,79% | 12.642.100 |
| 16/09/2025 | 81,01 | 81,48 | 80,54 | 81,09 | +0,09% | 1,16% | 10.065.900 |
| 15/09/2025 | 82,11 | 82,75 | 80,92 | 81,02 | -2,16% | 2,23% | 10.229.800 |
| 12/09/2025 | 84,62 | 85,18 | 82,80 | 82,81 | -2,75% | 2,81% | 9.939.500 |
| 11/09/2025 | 84,34 | 85,55 | 84,00 | 85,15 | +1,33% | 1,84% | 9.667.200 |
| 10/09/2025 | 84,27 | 84,57 | 83,54 | 84,03 | -0,69% | 1,22% | 13.073.300 |
| 09/09/2025 | 84,18 | 84,80 | 84,13 | 84,61 | +0,62% | 0,80% | 9.767.500 |
| 08/09/2025 | 84,16 | 84,32 | 82,82 | 84,09 | -0,73% | 1,78% | 13.111.200 |
| 05/09/2025 | 83,79 | 85,27 | 83,25 | 84,71 | +0,79% | 2,41% | 13.231.100 |
| 04/09/2025 | 84,20 | 84,41 | 83,00 | 84,05 | -0,15% | 1,67% | 12.554.800 |
| 03/09/2025 | 85,37 | 85,81 | 84,07 | 84,18 | -1,52% | 2,04% | 12.714.400 |
| 02/09/2025 | 84,50 | 85,50 | 84,34 | 85,48 | +1,62% | 1,37% | 11.642.700 |
| 29/08/2025 | 83,42 | 84,24 | 83,28 | 84,12 | +1,09% | 1,15% | 10.872.900 |
| 28/08/2025 | 84,25 | 84,25 | 82,65 | 83,21 | -1,02% | 1,90% | 14.485.300 |
| 27/08/2025 | 85,07 | 85,48 | 83,88 | 84,07 | -1,08% | 1,88% | 10.588.100 |
| 26/08/2025 | 85,56 | 85,59 | 84,67 | 84,99 | -0,38% | 1,08% | 14.062.700 |
| 25/08/2025 | 87,21 | 87,39 | 84,95 | 85,31 | -2,36% | 2,80% | 9.417.700 |
| 22/08/2025 | 87,50 | 87,84 | 86,76 | 87,37 | +1,50% | 1,23% | 11.977.400 |
| 21/08/2025 | 84,88 | 87,32 | 84,60 | 86,08 | +1,68% | 3,20% | 13.889.000 |
| 20/08/2025 | 85,31 | 86,25 | 84,55 | 84,66 | -0,32% | 1,99% | 8.904.700 |
| 19/08/2025 | 84,38 | 85,80 | 84,38 | 84,93 | +0,84% | 1,68% | 14.307.700 |
| 18/08/2025 | 84,26 | 85,15 | 84,08 | 84,22 | +0,01% | 1,27% | 8.273.600 |
| 15/08/2025 | 83,72 | 84,74 | 83,36 | 84,21 | +1,75% | 1,65% | 10.481.400 |
| 14/08/2025 | 82,01 | 83,40 | 81,60 | 82,76 | +0,06% | 2,19% | 10.217.600 |
| 13/08/2025 | 80,75 | 82,84 | 80,20 | 82,71 | +3,00% | 3,27% | 11.043.800 |
| 12/08/2025 | 80,47 | 80,94 | 79,67 | 80,30 | +0,34% | 1,58% | 7.852.700 |
| 11/08/2025 | 80,96 | 81,64 | 79,63 | 80,03 | -0,82% | 2,48% | 8.210.700 |